Article Information
History
- October 25, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Dong Xu1,
- Fei Yang2,
- Yang Chen3,
- Hong Zhu4,
- Haijian Sun4,
- Tong Shen4,
- Yongkang Zhu4,
- Guowei Zhou4,
- Dexuan Chen4,
- Xiaojun Yang5,
- Kai Lin6,* and
- Cunbing Xia4,*
- 1Department of General Surgery, Gaochun People’s Hospital, Nanjing, Jiangsu, China
- 2Department of Internal Medicine, Gaochun People’s Hospital, Nanjing, Jiangsu, China
- 3Department of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China
- 4Department of General Surgery, Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, China
- 5Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
- 6Nanjing Medical University, Nanjing, Jiangsu, China
- ↵*Corresponding author : Kai Lin, seelinc{at}hotmail.com, Cunbing Xia, xiacunbing{at}njucm.edu.cn
Dong Xu and Fei Yang contributed equally to the article.
Posted October 25, 2022.
A novel cuproptosis-related gene signature for the prediction of liver cancer prognosis identified DLAT is a potential therapeutic target
